IBT
AKCA

International Biotechnology Trust’s Akcea Therapeutics Inc AKCA Stock Holding History

International Biotechnology Trust’s Portfolio AKCA Stock Details AKCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-31,723
Closed -$536K – 69
2019
Q4 		$536K Hold
31,723
– – 0.19% 56
2019
Q3 		$488K Hold
31,723
– – 0.23% 52
2019
Q2 		$743K Sell
31,723
-42,885
-57% -$1.06M 0.28% 57
2019
Q1 		$2.11M Buy
+74,608
New +$2.17M 0.78% 37

Other funds holding AKCA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

International Biotechnology Trust's AKCA Position: Q1 2020 in Review

International Biotechnology Trust sold out of Akcea Therapeutics Inc (AKCA) in Q1 2020, closing a stake of 31,723 shares — an estimated $536K sold.

International Biotechnology Trust first reported a position in AKCA in Q1 2019 and held it in 4 quarters. The position peaked at $2.11M in Q1 2019. 77 funds tracked by Wall St. Rank hold AKCA as of Q1 2020.

  • International Biotechnology Trust reported no remaining Akcea Therapeutics Inc position as of Q1 2020 after selling out during the quarter.
  • International Biotechnology Trust sold 31,723 Akcea Therapeutics Inc shares in Q1 2020, an estimated $536K.
  • International Biotechnology Trust first reported a position in Akcea Therapeutics Inc in Q1 2019 and held it in 4 quarters.
  • International Biotechnology Trust's Akcea Therapeutics Inc position peaked at $2.11M in Q1 2019.
  • 77 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q1 2020.

Based on International Biotechnology Trust's 13F filing for Q1 2020, filed 18 May 2020.